We observed that a forward primer based on the new sequence (PCA3-4) together with a reverse primer for exon 2 very efficiently amplified PCA3 in PCa (7/8) and metastases samples (7/8) but failed to detect PCA3 in BPH samples (0/8) (Fig 1B). The gene discussed is PCA3; the disease is benign prostatic hyperplasia.